Zachary Roberts
Directeur Technique/Scientifique/R&D chez ALLOGENE THERAPEUTICS, INC.
Fortune : 109 309 $ au 30/04/2024
Postes actifs de Zachary Roberts
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ALLOGENE THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 03/01/2023 | - |
Historique de carrière de Zachary Roberts
Anciens postes connus de Zachary Roberts
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| INSTIL BIO, INC. | Directeur Technique/Scientifique/R&D | 01/03/2020 | 11/11/2022 |
| KITE PHARMA INC | Directeur Technique/Scientifique/R&D | 01/02/2018 | 01/05/2019 |
| AMGEN INC. | Directeur Technique/Scientifique/R&D | 01/01/2015 | 01/07/2015 |
Formation de Zachary Roberts
| University of Maryland | Undergraduate Degree |
| University of Maryland School of Medicine | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 7 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 4 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| INSTIL BIO, INC. | Health Technology |
| ALLOGENE THERAPEUTICS, INC. | Health Technology |
| AMGEN INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
- Bourse
- Insiders
- Zachary Roberts
- Expérience
